Study of NMS-1116354 in Solid Tumors
A Phase I Dose-Escalation Study of NMS-1116354 in Adult Patients With Advanced Solid Tumors
Sponsor: Nerviano Medical Sciences
Terminated
Discontinuation of clinical investigation with NMS-1116354
Other terminated trials from Nerviano Medical Sciences
Other Advanced Solid Tumors trials with similar outcome
Listed as NCT01016327, this PHASE1 trial focuses on Advanced Solid Tumors and remains terminated or withdrawn. Sponsored by Nerviano Medical Sciences, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nerviano Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .